72 results on '"Singh, Steven"'
Search Results
2. Imaging Modality for Left Ventricular Ejection Fraction Estimation and Effect of Implantable Cardioverter Defibrillator on Mortality in Patients with Heart Failure
3. Outcomes of Premature Ventricular Contraction–Cardiomyopathy in the Veteran Population
4. Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation
5. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
6. POOR OUTCOMES ASSOCIATED WITH DIGOXIN DISCONTINUATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) MAY DIFFER BY BETA-BLOCKER USE
7. DIGOXIN INITIATION IS NOT ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE AND ATRIAL FIBRILLATION: INSIGHTS FROM THE MEDICARE-LINKED OPTIMIZE-HF REGISTRY
8. Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial
9. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction
10. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
11. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
12. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
13. OUTCOMES IN HOSPITALIZED OLDER AFRICAN AMERICAN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
14. ISOLATED SYSTOLIC HYPERTENSION (ISH) BY NEW ACC/AHA HYPERTENSION (HTN) GUIDELINES AND OUTCOMES IN OLDER ADULTS OVER 23 YEARS IN THE CARDIOVASCULAR HEALTH STUDY (CHS)
15. ADMISSION-TO-DISCHARGE WEIGHT CHANGE AND 30-DAY POST-DISCHARGE OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF)
16. ASSOCIATION OF ATRIAL FIBRILLATION AND OUTCOMES IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED AND REDUCED EJECTION FRACTION (HFPEF AND HFREF)
17. Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction
18. Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate
19. PRIOR HEART FAILURE (HF) HOSPITALIZATION AND 30-DAY AND 1-YEAR OUTCOMES IN PATIENTS WITH HF AND PRESERVED EJECTION FRACTION (HFPEF)
20. PREDICTORS OF 6-MONTH HEART FAILURE READMISSION AND DEATH IN OLDER PATIENTS WITH HEART FAILURE WITH PRESERVED VERSUS REDUCED EJECTION FRACTION
21. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction
22. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial
23. Detection and Management of Geographic Disparities in the TOPCAT Trial
24. Pulmonary Effect of Amiodarone in Patients With Heart Failure fn1fn1This study was supported by the Department of Veterans Affairs Cooperative Studies Program of the Medical Research Service (Washington, D.C.), Sanofi Winthrop Recherche (Paris, France) and Wyeth-Ayerst Laboratories (Philadelphia, Pennsylvania)
25. The Burden of Cardiovascular Morbidities in Veteran With OSA
26. Comparative pharmacophysiology of vernakalant, ranolazine, and d-sotalol in canine pulmonary vein sleeve preparations: new flavors or same old taste?
27. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: A substudy of the SAFE-T trial
28. Thyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation
29. Mortality Outcomes According to Frequency of Right Ventricular Pacing (RVP): Does More RVP Shorten Survival?
30. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure
31. Reply
32. Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation
33. The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: Insights from the Mode Selection Trial (MOST)
34. Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
35. The effects of maintenance of sinus rhythm on quality of life and exercise treadmill capacity in patients with persistent atrial fibrillation. A veterans affairs cooperative study
36. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004
37. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
38. Exercise capacity and heart rate recovery as predictors of coronary heart disease events, in patients with heterozygous Familial Hypercholesterolemia
39. The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction
40. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])
41. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery
42. The association of the heart failure score with mortality and hospitalizations in pacemaker patients
43. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)
44. QRS duration and mortality in patients with congestive heart failure
45. Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects
46. Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis
47. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function
48. Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy
49. Effects of amiodarone on tumor necrosis factor-α levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
50. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.